Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding epitope immunodominance in HIV Env using cryoEM and machine learning.

bioRxiv : the preprint server for biology·2026
Same author

HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trial.

Nature communications·2025
Same author

A modification to heptad repeat 1 of gp41 improves yield and/or quality of soluble pre-fusion HIV-1 envelope glycoprotein trimers.

Journal of virology·2025
Same author

Plasma membrane CYBDOM proteins catalyse apoplastic AsA regeneration and interact with RbohD to activate autophagy and drought tolerance in plants.

Nature plants·2025
Same author

The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.

Nature reviews. Microbiology·2025
Same author

Germline-targeting HIV Envelope SOSIP immunization more frequently elicits broadly-neutralizing antibody precursor responses in infant compared to juvenile rhesus macaques.

bioRxiv : the preprint server for biology·2025
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.4K

Progress on priming HIV-1 immunity.

Rogier W Sanders1,2,3, John P Moore3

  • 1Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, Netherlands.

Science (New York, N.Y.)
|May 16, 2024
PubMed
Summary
This summary is machine-generated.

Four new studies reveal the complex process for creating broadly active human immunodeficiency virus type 1 (HIV-1) antibodies. This research advances understanding of antibody generation for potential HIV therapies.

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

9.0K
Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.1K

Related Experiment Videos

Last Updated: May 5, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

17.4K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

9.0K
Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.1K

Area of Science:

  • Immunology
  • Virology
  • Antibody Engineering

Background:

  • Developing broadly active HIV-1 antibodies is crucial for an effective vaccine or therapy.
  • The natural antibody maturation process is complex and not fully understood.
  • Previous efforts have faced challenges in eliciting antibodies with broad neutralizing activity.

Purpose of the Study:

  • To elucidate the multistep pathway for generating broadly active HIV-1 antibodies.
  • To identify key factors and intermediates in antibody development.
  • To inform the design of novel HIV-1 vaccine strategies.

Main Methods:

  • Analysis of longitudinal B cell populations.
  • Deep sequencing of antibody genes.
  • In vitro functional assays to assess antibody neutralization.
  • Computational modeling of antibody evolution.

Main Results:

  • Identification of specific B cell subsets involved in antibody maturation.
  • Characterization of sequential mutations required for broad neutralizing activity.
  • Demonstration of stepwise progression towards broadly neutralizing antibodies.
  • Insights into the germinal center reactions driving antibody development.

Conclusions:

  • The multistep pathway involves specific genetic and cellular events.
  • Understanding this pathway is key to designing immunogens for vaccine development.
  • This research provides a roadmap for engineering potent HIV-1 neutralizing antibodies.